News

Todd Motto, vice president of sales and marketing, Meridian Bioscience commented, “Following a thorough evaluation of the Australian and Argentinean markets, it is clear that Immuno Pty and

Before joining Amylin, Mr Mihalik was vice president of global brand development diabetes and endocrine platform team leader at Eli Lilly and Company. Mr Mihalik will oversee marketing

The Phase I clinical trial was initiated to evaluate the safety, tolerability and pharmacokinetics of ON 01210.Na in healthy volunteers. Data from this initial trial will be used

The board also announced that it has commenced a search for a permanent replacement for departing president and CEO, Arie Cohen, who has left the company to pursue

Renamed Rem Medical Clinical Research, the new clinical research division is working closely with pharmaceutical companies and their contract research organizations to provide Phase II-IV trial services to

Telavancin is a bactericidal, once-daily injectable investigational antibiotic with a multifunctional mechanism of action. Telavancin was discovered by Theravance in a research program dedicated to finding new antibiotics

Prior to joining Aragon Surgical, Mr Snow served as director of sales and marketing at Medlogics, a cardiology device company. Prior to Medlogics, Mr Snow served at Rubicor

AstraZeneca markets Prilosec for the treatment of duodenal/gastric ulcers and gastro-esophageal reflux disease. The company’s versions of generic Prilosec (including previously approved and marketed 10mg and 20mg capsules)

This patent, exclusively licensed from the Massachusetts General Hospital, provides FluoroPharma with additional patent claims that cover imaging of atherosclerotic plaque inflammation and rupture. Kundakovic, president of FluoroPharma,